https://www.ncbi.nlm.nih.gov/Structure/pdb/4YTC
Tyrosine-protein kinase JAK2N~3~-phenyl-1-[6-(phenylamino)pyrimidin-4-yl]-1H-1,2,4-triazole-3,5-diamine
discoveryvxdecernotinibpotentselective
https://www.technologynetworks.com/drug-discovery/news/ym-biosciences-reports-phase-iii-data-for-jak-inhibitor-cyt387-at-ash-2012-214388
68% transfusion independence response rate and 37% durable spleen response rate.
ym biosciencesjak inhibitorreportsphaseii